{"id":"W2559291799","doi":"10.1371/journal.pone.0166318","title":"Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases; National Cancer Institute; Public Health Agency of Canada; National Institutes of Health; Strong; Public Health Agency; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases","keywords":"Lamivudine; Zidovudine; Virology; Ebola virus; Virus; Multiplicity of infection; Hepatitis B virus; Nucleoside analogue; Antiviral drug; Vero cell; Biology; Viral disease; Nucleoside","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323484,0.0004042631,0.000620362,0.0005357489,0.0002178712,0.0004737453,0.000551227,0.0004663701,0.0006579662],"category_scores_gemma":[0.0005052867,0.0001991317,0.0004793514,0.0005772827,0.0001969866,0.0002909562,0.0002425791,0.000485493,0.0001688494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002475003,"about_ca_system_score_gemma":0.0002215327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001653482,"about_ca_topic_score_gemma":0.00211493,"domain_scores_codex":[0.9994944,0.0001650314,0.00005806737,0.0000542014,0.0001575374,0.00007082576],"domain_scores_gemma":[0.9997725,0.00008212068,0.00003256237,0.00001833947,0.00006060676,0.00003387504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001101428,0.0004334612,0.001788883,0.0002930062,0.00009638748,0.00009973902,0.00009690158,0.0004145182,0.9844364,0.00006543415,0.00008459462,0.01108921],"study_design_scores_gemma":[0.0003077208,0.0290332,0.03279046,0.00003939832,0.0003401027,0.00062597,0.0002477686,0.001705865,0.9274344,0.0000584713,0.007380374,0.00003625171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867662,0.01135955,0.0005656445,0.00006650852,0.00003381959,0.00006724791,0.000314688,0.00001319738,0.0008130935],"genre_scores_gemma":[0.990781,0.005698237,0.001752463,0.00005354055,0.00002985003,0.0000485438,0.0007750547,0.000006327438,0.0008548802],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001653482,"threshold_uncertainty_score":0.003287733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1410630567562435,"score_gpt":0.3355052994124356,"score_spread":0.1944422426561921,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}